Breast Cancer Screening: Updated Recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations

Ng A, Garber J, Diller L, Birdwell R, Feng Y, Neuberg D . Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013; 31(18):2282-8. DOI: 10.1200/JCO.2012.46.5732. View

Gotzsche P, Jorgensen K . Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013; (6):CD001877. PMC: 6464778. DOI: 10.1002/14651858.CD001877.pub5. View

Sung J, Dershaw D . Breast magnetic resonance imaging for screening high-risk women. Magn Reson Imaging Clin N Am. 2013; 21(3):509-17. DOI: 10.1016/j.mric.2013.02.006. View

Machado Badan G, Roveda Junior D, Ferreira C, de Noronha Junior O . Complete internal audit of a mammography service in a reference institution for breast imaging. Radiol Bras. 2015; 47(2):74-8. PMC: 4337155. DOI: 10.1590/S0100-39842014000200007. View

Freitas-Junior R, Rodrigues D, Correa R, Peixoto J, de Oliveira H, Sousa Rahal R . Contribution of the Unified Health Care System to mammography screening in Brazil, 2013. Radiol Bras. 2016; 49(5):305-310. PMC: 5094819. DOI: 10.1590/0100-3984.2014.0129. View

Bitencourt A . Subdividing BI-RADS category 4 breast lesions observed on magnetic resonance imaging: Is it feasible?. Radiol Bras. 2016; 49(3):V. PMC: 4938441. DOI: 10.1590/0100-3984.2016.49.3e1. View

Machado Badan G, Roveda Junior D, Piato S, De Faria Castro Fleury E, Campos M, Pecci C . Diagnostic underestimation of atypical ductal hyperplasia and ductal carcinoma in situ at percutaneous core needle and vacuum-assisted biopsies of the breast in a Brazilian reference institution. Radiol Bras. 2016; 49(1):6-11. PMC: 4770389. DOI: 10.1590/0100-3984.2014.0110. View

Franca L, Bitencourt A, Paiva H, Silva C, Pereira N, Paludo J . Role of magnetic resonance imaging in the planning of breast cancer treatment strategies: comparison with conventional imaging techniques. Radiol Bras. 2017; 50(2):76-81. PMC: 5396996. DOI: 10.1590/0100-3984.2015.0124. View

Saraiva de Castro Mattos J, Mauad E, Syrjanen K, Longatto-Filho A, Haikel R, Vieira R . The impact of breast cancer screening among younger women in the Barretos Region, Brazil. Anticancer Res. 2013; 33(6):2651-5. View

10.

Tarone R . The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer. 1995; 75(4):997-1003. DOI: 10.1002/1097-0142(19950215)75:4<997::aid-cncr2820750415>3.0.co;2-m. View

11.

Numan Hellquist B, Duffy S, Abdsaleh S, Bjorneld L, Bordas P, Tabar L . Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2010; 117(4):714-22. DOI: 10.1002/cncr.25650. View

12.

Friedewald S, Rafferty E, Rose S, Durand M, Plecha D, Greenberg J . Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014; 311(24):2499-507. DOI: 10.1001/jama.2014.6095. View

13.

Riedl C, Luft N, Bernhart C, Weber M, Bernathova M, Tea M . Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol. 2015; 33(10):1128-35. PMC: 5526626. DOI: 10.1200/JCO.2014.56.8626. View

14.

Sung J, Malak S, Bajaj P, Alis R, Dershaw D, Morris E . Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology. 2011; 261(2):414-20. DOI: 10.1148/radiol.11110091. View

15.

Hartman M, Drotman M, Arleo E . Annual screening mammography for breast cancer in women 75 years old or older: to screen or not to screen. AJR Am J Roentgenol. 2015; 204(5):1132-6. DOI: 10.2214/AJR.14.13394. View

16.

Smith R, Andrews K, Brooks D, DeSantis C, Fedewa S, Lortet-Tieulent J . Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2016; 66(2):96-114. DOI: 10.3322/caac.21336. View

17.

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

18.

Tabar L, Chen T, Hsu C, Wu W, Yen A, Chen S . Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review. J Med Screen. 2016; 24(1):27-33. PMC: 5308404. DOI: 10.1177/0969141316631375. View

19.

Forouzanfar M, Foreman K, Delossantos A, Lozano R, Lopez A, Murray C . Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011; 378(9801):1461-84. DOI: 10.1016/S0140-6736(11)61351-2. View

20.

Phi X, Saadatmand S, de Bock G, Warner E, Sardanelli F, Leach M . Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. Br J Cancer. 2016; 114(6):631-7. PMC: 4800299. DOI: 10.1038/bjc.2016.32. View